Clinical research network partners exclusively with Develop Consulting
The Global Clinical Site Accreditation (GCSA) has named Develop Consulting as its exclusive partner for accreditations and improvement work across the clinical research industry.
The GCSA was launched in 2020 with the aim of supporting the development of the clinical research industry by providing sites with an internationally-recognised benchmark.
Developed with the oversight of the GCSA Global Advisory board (made up of industry experts, sponsors, clinical officers and trusts), the accreditation ensures sponsors, sites and staff deliver a high-quality experience to all stakeholders.
To achieve accreditation, sites are independently assessed against the GCSA accreditation’s robust quality standards and are awarded a quality mark for reaching specific criteria in seven areas from feasibility and start-up to study and patient management.
Sites seeking to achieve accreditation will work with teams from Develop Consulting during the 3-6 months process. The Midlands-based consulting firm has been appointed the exclusive partner for GCSA on the back of its “extensive knowledge of the healthcare sector” and “successful working partnership” with the network since its inception.
Chair of the GCSA Board, Jacqueline Johnson North, said: “GCSA is setting the standard for organisations globally undertaking clinical trials and we are delighted to be working with Develop Consulting to deliver this standard across the UK.”
Steve Boam, CEO of Develop Consulting said: “We are proud to have been appointed as the exclusive delivery team for such a unique accreditation which will make such a huge difference to clinical research. Our experienced healthcare team will be able to guide sites as they strive to achieve the accreditation.”
“And for sites that require improvement, our team will provide a clear and bespoke route to improvement, so they are able to achieve the accreditations at a later date.”
